Koji Yoshinaga   Takayuki Horii   Hiroki Hamano   Runa Eta   Tomoko Ozaki   Yuki Orikawa   Kazuyoshi Yoshii   Yoshihiro Kawabata   Yuko Hori   Koichi Seto   Mineo Takei   Yasushi Kuraishi   
BIOLOGICAL & PHARMACEUTICAL BULLETIN 33(2) 244-248 2010年2月 [査読有り]
Z-360, a novel cholecystokinin(2) (CCK2) receptor antagonist, has been developed as a therapeutic drug for pancreatic cancer and showed pain relief action in phase Ib/IIa clinical trial. This study was attempted to elucidate the analgesic efficacy...